| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $192,006,541 ) (Continued on the next page) |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01NS144826 | Neurological pathophysiology of disrupted O-glycosylation in congenital disorders of glycosylation | 000 | 2 | NIH | 8/7/2026 | $686,889 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | M0131292 | Behavioral Health Workforce Education and Training (BHWET) Program | 00 | 10 | HRSA | 6/2/2026 | $591,102 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K23DA063939 | The Adolescent Surgery Experience: Preoperative Anticipatory Guidance and Postoperative Opioid Misuse (POM) | 000 | 2 | NIH | 7/21/2026 | $178,386 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01MH133843 | Precision brain charts for imaging-genomics of schizophrenia and the psychosis spectrum | 000 | 4 | NIH | 8/20/2026 | $770,271 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI185544 | High Resolution, Whole Genome Tracking of Pathogen Transmission and Infection in the Neonatal ICU (NICU) | 000 | 2 | NIH | 6/18/2026 | $873,921 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA193776 | Improving risk allocation and developing novel therapies for children with T-ALL and T-LL | 001 | 9 | NIH | 4/17/2026 | $73,733 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA193776 | Improving risk allocation and developing novel therapies for children with T-ALL and T-LL | 000 | 9 | NIH | 1/27/2026 | $663,617 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | UM454988 | Autism Research Consortium | 00 | 2 | HRSA | 7/28/2026 | $1,161,404 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01NS131512 | A computational phenotyping approach to characterize neurogenetic disorders | 000 | 4 | NIH | 4/7/2026 | $688,207 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U01DK066174 | Chronic Kidney Disease in Children (CKiD) | 002 | 25 | NIH | 7/31/2026 | $0 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U01DK066174 | Chronic Kidney Disease in Children (CKiD) | 002 | 25 | NIH | 7/31/2026 | $0 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U01DK066174 | Chronic Kidney Disease in Children (CKiD) | 002 | 25 | NIH | 7/31/2026 | $0 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U01DK066174 | Chronic Kidney Disease in Children (CKiD) | 001 | 25 | NIH | 7/24/2026 | $175,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U01DK066174 | Chronic Kidney Disease in Children (CKiD) | 001 | 25 | NIH | 7/24/2026 | $832,005 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U01DK066174 | Chronic Kidney Disease in Children (CKiD) | 001 | 25 | NIH | 7/24/2026 | $300,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI194422 | Genetics-based discovery of novel genes regulating follicular helper T cell function | 000 | 1 | NIH | 7/8/2026 | $906,255 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK143997 | Partnering with Adolescents to Choose and Implement Technology in the Management of T1D (PAC-IT) | 000 | 1 | NIH | 4/28/2026 | $356,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK141778 | Urinary peptidomics for neurogenic bladder risk stratification in patients with spina bifida | 000 | 1 | NIH | 2/6/2026 | $796,742 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K25HL186164 | Computational and Experimental Investigations of Deformation-Driven Molecular Pathways in Single Right Ventricle Congenital Heart Disease | 000 | 1 | NIH | 7/8/2026 | $115,584 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21DA065088 | Antioxidant and blood flow profiling in individuals with HIV | 001 | 1 | NIH | 3/11/2026 | $0 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21DA065088 | Antioxidant and blood flow profiling in individuals with HIV | 000 | 1 | NIH | 2/20/2026 | $456,268 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R03HD122148 | Disease trajectories of rare genomic variants contributing to lesional brain disorders | 000 | 1 | NIH | 5/14/2026 | $356,000 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08DE035951 | Mapping the developmental effects of TBCK loss in dental and craniofacial mineralization | 000 | 1 | NIH | 7/8/2026 | $162,508 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK144396 | Real-world Comparative Treatment Effectiveness and Surrogate Outcome Evaluation in Membranous Nephropathy using Observational Data | 000 | 1 | NIH | 5/19/2026 | $949,759 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21NS147239 | Understanding the Role of BLOC1S1 in Myelin Development | 000 | 1 | NIH | 4/28/2026 | $489,500 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL183262 | Unlocking the potential of wearable sensors to measure physical activity and predict clinical worsening in pediatric pulmonary hypertension | 000 | 1 | NIH | 8/13/2026 | $1,068,774 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA300077 | Bioinspired virus-like nanovaccines boost CAR T and endogenous T cells in tandem against solid tumors with antigen heterogeneity | 000 | 1 | NIH | 5/19/2026 | $737,082 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01AI201538 | Developing technologies to identify dynamics of PTM enzyme-substrate networks during infections | 000 | 1 | NIH | 8/17/2026 | $849,915 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R21AI199187 | Using a hollow fiber infection model to investigate the role of ceftazidime-avibactam in combination with meropenem in the prevention and treatment of mutant KPC-producing infections | 000 | 1 | NIH | 7/16/2026 | $448,292 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA312142 | Multi-modal data integration and functional screening to discover druggable targets in pediatric low-grade glioma | 000 | 1 | NIH | 8/12/2026 | $737,908 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL188167 | Translesion Synthesis DNA Polymerases in Mitigating Replication Stress | 000 | 1 | NIH | 8/17/2026 | $850,577 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08CA304485 | Novel mechanisms of acute myeloid leukemia resistance to cell therapy | 000 | 1 | NIH | 8/17/2026 | $263,656 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U34CA308743 | Cancer screening with cell-free DNA in Li-Fraumeni Syndrome: Feasibility study prior to national trial | 000 | 1 | NIH | 7/16/2026 | $427,064 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | F32DK149663 | Biomarkers for Thrombotic Risk Stratification in Nephrotic Syndrome | 000 | 1 | NIH | 7/16/2026 | $86,824 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DC023554 | Verbal and Non-Verbal Predictors of Successful Communication Within and Across Neurotype: Leveraging Context-Dependent, Next-Generation Digital Phenotyping | 000 | 1 | NIH | 5/18/2026 | $717,468 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08DK149313 | Intestinal Smooth Muscle Phenotypic Class Switching in Myopathic Pediatric Intestinal Pseudo-obstruction | 000 | 1 | NIH | 8/19/2026 | $160,056 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K24HL188310 | Mentoring Patient-Oriented Research to Improve Neonatal Pulmonary Outcomes | 000 | 1 | NIH | 8/19/2026 | $128,466 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL180442 | Lung Injury in ONcologic Stem cell transplants (LIONS) | 000 | 2 | NIH | 8/20/2026 | $861,976 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R03DK147724 | Control of hemoglobin expression by the chromatin remodeler CHD7 | 000 | 1 | NIH | 5/7/2026 | $133,500 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01CA303081 | Characterization and targeting of HSPC-like blasts in high-risk leukemias | 000 | 1 | NIH | 7/3/2026 | $744,511 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08DK141964 | Elucidating Effector CD8 T-Cell – Kupffer Cell InterferonGamma Interaction in Pediatric Activated T-cell Acute Liver Failure | 000 | 2 | NIH | 7/22/2026 | $159,408 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08AI203036 | Influenza and Hydroxychloroquine Shaping of Self-Antigen Presentation in Systemic Lupus Erythematosus | 000 | 1 | NIH | 8/12/2026 | $165,456 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01DK145085 | Early Identification and Prevention of Type 1 Diabetes Using Polygenic Risk Score Screening and CAR-T-reg Therapy | 000 | 1 | NIH | 8/10/2026 | $889,998 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | AY2AX000199 | Realizing and Sustaining Personalized In Vivo Gene Editing Therapeutics | 000 | 1 | NIH | 7/6/2026 | $6,084,531 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | K08MH138821 | Role of Mitochondria in Variable Penetrance of Schizophrenia in 22q11.2 Deletion Syndrome via Influence on Presynaptic Mechanisms of Glutamate Release | 000 | 1 | NIH | 7/15/2026 | $721,440 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HL180417 | Lessons from Hardikar Syndrome: MED12 as a novel regulator of vasculogenesis | 000 | 1 | NIH | 7/7/2026 | $889,804 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54HL185006 | ARDVARC-Advancing Rare Disorders: Vascular mAlformation Research Network with CaNVAS | 000 | 2 | NIH | 8/7/2026 | $752,067 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | U54HL185006 | ARDVARC-Advancing Rare Disorders: Vascular mAlformation Research Network with CaNVAS | 000 | 2 | NIH | 8/7/2026 | $872,650 |
| | 2026 | 2026 | THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 3401 CIVIC CENTER BLVD | PHILADELPHIA | PA | 19104-4319 | PHILADELPHIA | USA | R01HD117777 | Medicaid Enrollment and Outcomes Over the Reproductive Lifecourse | 000 | 2 | NIH | 6/30/2026 | $692,628 |
|
